다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of the American College of Cardiology, v.71 no.1, 2018년, pp.69 - 84
Gadde, Kishore M. , Martin, Corby K. , Berthoud, Hans-Rudolf , Heymsfield, Steven B.
AI-Helper
Central Illustration[Figure]AbstractObesity continues to be among the top health concerns across the globe. Despite our failure to contain the high prevalence of obesity, we now have a better understanding of its pathophysiology, and how excess adiposity leads to type 2 diabetes, hypertension, and c...
N Engl J Med Afshin 377 13 2017 10.1056/NEJMoa1614362 Health effects of overweight and obesity in 195 countries over 25 years
N Engl J Med Heymsfield 376 1492 2017 10.1056/NEJMra1514009 Mechanisms, pathophysiology, and management of obesity
JAMA Mozaffarian 313 2421 2015 10.1001/jama.2015.5941 The 2015 US Dietary Guidelines: lifting the ban on total dietary fat
Am J Clin Nutr de Souza 95 614 2012 10.3945/ajcn.111.026328 Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial
Endocr Rev Schwartz 38 267 2017 10.1210/er.2017-00111 Obesity pathogenesis: an Endocrine Society scientific statement
Gastroenterology Hall 152 1718 2017 10.1053/j.gastro.2017.01.052 Obesity energetics: body weight regulation and the effects of diet composition
Gastroenterology Fall 152 1695 2017 10.1053/j.gastro.2017.01.054 Recent advances in human genetics and epigenetics of adiposity: pathway to precision medicine?
Nature Locke 518 197 2015 10.1038/nature14177 Genetic studies of body mass index yield new insights for obesity biology
J Endocrinol Invest Angulo 38 1249 2015 10.1007/s40618-015-0312-9 Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings
Diab Vasc Dis Res Speakman 3 7 2006 10.3132/dvdr.2006.010 Thrifty genes for obesity and the metabolic syndrome: time to call off the search?
Int J Obes (Lond) Speakman 32 1611 2008 10.1038/ijo.2008.161 Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the 'drifty gene' hypothesis
J Epidemiol Community Health Barker 58 114 2004 10.1136/jech.58.2.114 Developmental origins of adult health and disease
Curr Opin Clin Nutr Metab Care Cordero 18 361 2015 10.1097/MCO.0000000000000179 Epigenetics of obesity: beyond the genome sequence
Physiol Rev Brobeck 26 541 1946 10.1152/physrev.1946.26.4.541 Mechanism of the development of obesity in animals with hypothalamic lesions
Annu Rev Physiol Sternson 79 401 2017 10.1146/annurev-physiol-021115-104948 Three pillars for the neural control of appetite
Physiol Behav Berthoud 104 29 2011 10.1016/j.physbeh.2011.04.051 The lateral hypothalamus as integrator of metabolic and environmental needs: from electrical self-stimulation to opto-genetics
Gastroenterology Berthoud 152 1728 2017 10.1053/j.gastro.2016.12.050 Blaming the brain for obesity: Integration of hedonic and homeostatic mechanisms
Obes Rev Carnell 13 43 2012 10.1111/j.1467-789X.2011.00927.x Neuroimaging and obesity: current knowledge and future directions
Gut Scholtz 63 891 2014 10.1136/gutjnl-2013-305008 Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
Int J Obes (Lond) Hollmann 36 648 2012 10.1038/ijo.2011.125 Neural correlates of the volitional regulation of the desire for food
Obesity (Silver Spring) Goldman 21 2189 2013 10.1002/oby.20575 Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery
Behav Brain Res Wijngaarden 287 127 2015 10.1016/j.bbr.2015.03.016 Obesity is marked by distinct functional connectivity in brain networks involved in food reward and salience
Proc Nutr Soc Berthoud 71 390 2012 10.1017/S0029665112000559 Neural and metabolic regulation of macronutrient intake and selection
J Am Diet Assoc Franz 107 1755 2007 10.1016/j.jada.2007.07.017 Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
Transl Psychiatry Madra 6 2016 10.1038/tp.2016.35 BDNF-Val66Met variant and adolescent stress interact to promote susceptibility to anorexic behavior in mice
Br J Sports Med King 46 315 2012 10.1136/bjsm.2010.082495 Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss
Nat Rev Neurosci Hillman 9 58 2008 10.1038/nrn2298 Be smart, exercise your heart: exercise effects on brain and cognition
1842 A Treatise on Man and the Development of His Faculties [Knox R, translator]
Am J Clin Nutr Heymsfield 100 1455 2014 10.3945/ajcn.114.088831 Scaling of adult body weight to height across sex and race/ethnic groups: relevance to BMI
J Chronic Dis Keys 25 329 1972 10.1016/0021-9681(72)90027-6 Indices of relative weight and obesity
JAMA Heymsfield 309 87 2013 10.1001/jama.2012.185445 Does body mass index adequately convey a patient's mortality risk?
J Am Coll Cardiol Jensen 63 2985 2014 10.1016/j.jacc.2013.11.004 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Circulation Poirier 123 1683 2011 10.1161/CIR.0b013e3182149099 Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association
Lancet 363 157 2004 10.1016/S0140-6736(03)15268-3 Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
JAMA Lauer 266 231 1991 10.1001/jama.1991.03470020057032 The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study
Am J Physiol Regul Integr Comp Physiol Davy 286 R803 2004 10.1152/ajpregu.00707.2003 Obesity and hypertension: two epidemics or one?
Circ Res Staerk 120 1501 2017 10.1161/CIRCRESAHA.117.309732 Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes
N Engl J Med Kenchaiah 347 305 2002 10.1056/NEJMoa020245 Obesity and the risk of heart failure
Circulation Aune 133 639 2016 10.1161/CIRCULATIONAHA.115.016801 Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies
Circulation Pencina 119 3078 2009 10.1161/CIRCULATIONAHA.108.816694 Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study
Am J Epidemiol Sun 172 1442 2010 10.1093/aje/kwq306 Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors
Arch Intern Med Church 165 2114 2005 10.1001/archinte.165.18.2114 Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes
Mayo Clin Proc Carbone 92 266 2017 10.1016/j.mayocp.2016.11.001 Obesity and heart failure: focus on the obesity paradox
Curr Opin Clin Nutr Metab Care Prado 18 535 2015 10.1097/MCO.0000000000000216 Body composition phenotypes and obesity paradox
Obesity (Silver Spring) Shen 14 727 2006 10.1038/oby.2006.83 Waist circumference correlates with metabolic syndrome indicators better than percentage fat
Lancet Yusuf 366 1640 2005 10.1016/S0140-6736(05)67663-5 Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
PLoS One Krakauer 7 2012 10.1371/journal.pone.0039504 A new body shape index predicts mortality hazard independently of body mass index
Obesity Thomas 21 2264 2013 10.1002/oby.20408 Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model
J Epidemiol Community Health Dhana 70 90 2016 10.1136/jech-2014-205257 Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality
Obesity (Silver Spring) Bergman 19 1083 2011 10.1038/oby.2011.38 A better index of body adiposity
Obes Res Shen 11 5 2003 10.1038/oby.2003.3 Adipose tissue quantification by imaging methods: a proposed classification
Trends Endocrinol Metab Heymsfield 26 688 2015 10.1016/j.tem.2015.10.003 Emerging technologies and their applications in lipid compartment measurement
Endocr Connect Wolf 6 R59 2017 10.1530/EC-17-0031 Heart, lipids, and hormones
Curr Opin Endocrinol Diabetes Obes Gadde 16 353 2009 10.1097/MED.0b013e3283304f90 Combination therapy for obesity and metabolic disease
Obes Rev Elfhag 6 67 2005 10.1111/j.1467-789X.2005.00170.x Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain
N Engl J Med Wing 355 1563 2006 10.1056/NEJMoa061883 A self-regulation program for maintenance of weight loss
JAMA Rock 304 1803 2010 10.1001/jama.2010.1503 Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial
J App Physiol Hill 99 765 2005 10.1152/japplphysiol.00137.2005 Role of physical activity in preventing and treating obesity
Circulation Thompson 107 3109 2003 10.1161/01.CIR.0000075572.40158.77 Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease
Obes Res Womble 12 1011 2004 10.1038/oby.2004.124 A randomized controlled trial of a commercial internet weight loss program
J Diabetes Sci Technol Stewart 5 178 2011 10.1177/193229681100500125 H.E.A.L.T.H.: efficacy of an internet/population-based behavioral weight management program for the U. S. Army
JAMA Tate 289 1833 2003 10.1001/jama.289.14.1833 Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial
Arch Intern Med Tate 166 1620 2006 10.1001/archinte.166.15.1620 A randomized trial comparing human e-mail counseling, computer-automated tailored counseling, and no counseling in an Internet weight loss program
Transl Behav Med Breton 1 523 2011 10.1007/s13142-011-0076-5 Weight loss-there is an app for that! But does it adhere to evidence-informed practices?
Curr Diab Rep Thomas 14 485 2014 10.1007/s11892-014-0485-1 Review of innovations in digital health technology to promote weight control
Obesity (Silver Spring) Martin 23 935 2015 10.1002/oby.21063 Efficacy of SmartLoss, a smartphone-based weight loss intervention: results from a randomized controlled trial
N Engl J Med Knowler 346 393 2002 10.1056/NEJMoa012512 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
Lancet Knowler 374 1677 2009 10.1016/S0140-6736(09)61457-4 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
Diabetes Care Pi-Sunyer 30 1374 2007 10.2337/dc07-0048 Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial
N Engl J Med Wing 369 145 2013 10.1056/NEJMoa1212914 Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
Lancet Diabetes Endocrinol Baum 5 808 2017 10.1016/S2213-8587(17)30176-6 Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial
N Engl J Med Foster 348 2082 2003 10.1056/NEJMoa022207 A randomized trial of a low-carbohydrate diet for obesity
Ann Intern Med Foster 153 147 2010 10.7326/0003-4819-153-3-201008030-00005 Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial
Nutr Metabo Cardiovasc Dis Clifton 24 224 2014 10.1016/j.numecd.2013.11.006 Long term weight maintenance after advice to consume low carbohydrate, higher protein diets: a systematic review and meta analysis
JAMA Pagoto 310 687 2013 10.1001/jama.2013.8601 A call for an end to the diet debates
Am J Clin Nutr Hjorth 106 499 2017 10.3945/ajcn.117.155200 Pretreatment fasting plasma glucose and insulin modify dietary weight loss success: results from 3 randomized clinical trials
N Engl J Med Appel 336 1117 1997 10.1056/NEJM199704173361601 A clinical trial of the effects of dietary patterns on blood pressure
N Engl J Med Estruch 368 1279 2013 10.1056/NEJMoa1200303 Primary prevention of cardiovascular disease with a Mediterranean diet
Expert Opin Pharmacother Gadde 15 809 2014 10.1517/14656566.2014.890590 Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice
Curr Diab Rep Gadde 17 34 2017 10.1007/s11892-017-0859-2 Pharmacotherapy of obesity: clinical trials to clinical practice
Yonsei Med J Kim 47 614 2006 10.3349/ymj.2006.47.5.614 Effects on weight reduction and safety of short-term phentermine administration in Korean obese people
Diabetes Obes Metab Kang 12 876 2010 10.1111/j.1463-1326.2010.01242.x Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
Obesity Aronne 21 2163 2013 10.1002/oby.20584 Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
Ann Intern Med Leblanc 155 434 2011 10.7326/0003-4819-155-7-201110040-00006 Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force
JAMA Yanovski 311 74 2014 10.1001/jama.2013.281361 Long-term drug treatment of obesity. A systematic and clinical review
Diabetes Care Torgerson 27 155 2004 10.2337/diacare.27.1.155 XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
N Engl J Med Smith 363 245 2010 10.1056/NEJMoa0909809 Multicenter, placebo-controlled trial of lorcaserin for weight management
J Clin Endocrinol Metab Fidler 96 3067 2011 10.1210/jc.2011-1256 A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial
Obesity O’Neil 20 1426 2012 10.1038/oby.2012.66 Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study
Obesity Smith 25 857 2017 10.1002/oby.21811 Coadministration of lorcaserin and phentermine for weight management: a 12-week, randomized, pilot safety study
N Engl J Med Pi-Sunyer 373 11 2015 10.1056/NEJMoa1411892 A randomized, controlled trial of 3.0 mg of liraglutide in weight management
JAMA Davies 314 687 2015 10.1001/jama.2015.9676 Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes randomized clinical trial
Lancet le Roux 389 1399 2017 10.1016/S0140-6736(17)30069-7 3 Years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Int J Obes Wadden 37 1443 2013 10.1038/ijo.2013.120 Weight maintenance and additional weight loss with liraglutide after low-calorie-diet induced weight loss: the SCALE Maintenance randomized study
N Engl J Med Marso 375 311 2016 10.1056/NEJMoa1603827 Liraglutide and cardiovascular outcomes in type 2 diabetes
Obesity Allison 20 330 2012 10.1038/oby.2011.330 Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)
Lancet Gadde 377 1341 2011 10.1016/S0140-6736(11)60205-5 Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Lancet Greenway 376 595 2010 10.1016/S0140-6736(10)60888-4 Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Obesity Wadden 19 110 2011 10.1038/oby.2010.147 Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial
Diabetes Care Hollander 36 4022 2013 10.2337/dc13-0234 Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes
JAMA Nissen 315 990 2016 10.1001/jama.2016.1558 Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial
JAMA Khera 315 2424 2016 10.1001/jama.2016.7602 Association of pharmacological treatments for obesity with weight loss and adverse effects: a systematic review and meta-analysis
JAMA Ikramuddin 312 915 2014 10.1001/jama.2014.10540 Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial
Nat Rev Gastroenterol Hepatol Lee 14 553 2017 10.1038/nrgastro.2017.80 Medical devices for the treatment of obesity
Obes Surg Angrisani 25 1822 2015 10.1007/s11695-015-1657-z Bariatric surgery worldwide 2013
Surg Obes Relat Dis Khorgami 13 774 2017 10.1016/j.soard.2017.01.031 Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates
JAMA Surg Maciejewski 151 1046 2016 10.1001/jamasurg.2016.2317 Bariatric surgery and long-term durability of weight loss
Can J Cardiol Piche 31 153 2015 10.1016/j.cjca.2014.12.014 How to choose and use bariatric surgery in 2015
N Engl J Med Schauer 370 2002 2014 10.1056/NEJMoa1401329 Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes
JAMA Ikramuddin 309 2240 2013 10.1001/jama.2013.5835 Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial
Diabetes Care Rubino 39 861 2016 10.2337/dc16-0236 Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations
Nat Rev Cardiol Beamish 13 730 2016 10.1038/nrcardio.2016.162 Cardiovascular effects of bariatric surgery
Diabetes Care Schauer 39 902 2016 10.2337/dc16-0382 Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes
Nat Rev Gastroenterol Hepatol Nguyen 14 160 2017 10.1038/nrgastro.2016.170 Bariatric surgery for obesity and metabolic disorders: state of the art
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.